advertisement

WGC-2021

11.3.3 Apraclonidine, brimonidine (425)

Showing records 1 to 25

Display only abstracts from IGR 20-4 in classification 11.3.3 Apraclonidine, brimonidine

Search within classification 11.3.3 Apraclonidine, brimonidine

84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Emad Eldeeb A
Drug Delivery 2019; 26: 509-521 (IGR: 21-1)


85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Nitta K
Clinical Ophthalmology 2020; 14: 213-219 (IGR: 21-1)


85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Wy S
Korean Journal of Ophthalmology 2020; 34: 19-26 (IGR: 21-1)


85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Wang N
Clinical Ophthalmology 2020; 14: 221-230 (IGR: 21-1)


84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Salah S
Drug Delivery 2019; 26: 509-521 (IGR: 21-1)


85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Shimamoto S
Clinical Ophthalmology 2020; 14: 213-219 (IGR: 21-1)


85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Kim YK
Korean Journal of Ophthalmology 2020; 34: 19-26 (IGR: 21-1)


85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Lu DW; Pan Y
Clinical Ophthalmology 2020; 14: 221-230 (IGR: 21-1)


84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Ghorab M
Drug Delivery 2019; 26: 509-521 (IGR: 21-1)


85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Wajima R
Clinical Ophthalmology 2020; 14: 213-219 (IGR: 21-1)


85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Jeoung JW
Korean Journal of Ophthalmology 2020; 34: 19-26 (IGR: 21-1)


85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Astakhov Y
Clinical Ophthalmology 2020; 14: 221-230 (IGR: 21-1)


85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Park KH
Korean Journal of Ophthalmology 2020; 34: 19-26 (IGR: 21-1)


85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Tachibana G
Clinical Ophthalmology 2020; 14: 213-219 (IGR: 21-1)


85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Iureva T
Clinical Ophthalmology 2020; 14: 221-230 (IGR: 21-1)


85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Yamada Y
Clinical Ophthalmology 2020; 14: 213-219 (IGR: 21-1)


85105 Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma
Ha A
Korean Journal of Ophthalmology 2020; 34: 19-26 (IGR: 21-1)


85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Domoto M
Clinical Ophthalmology 2020; 14: 213-219 (IGR: 21-1)


85183 Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
Adewale A; Walker TM
Clinical Ophthalmology 2020; 14: 221-230 (IGR: 21-1)


85182 The Effect of Brimonidine 0.1% on Disc Hemorrhage in Primary Open-Angle Glaucoma Patients
Takeda R; Takahashi Y; Sugiyama K
Clinical Ophthalmology 2020; 14: 213-219 (IGR: 21-1)


82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Duru Z
Cutaneous and Ocular Toxicology 2020; 39: 21-24 (IGR: 20-4)


82619 Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model
Zhou X
Experimental Eye Research 2019; 189: 107833 (IGR: 20-4)


82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Hwang HB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511 (IGR: 20-4)


82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Ozsaygili C
Cutaneous and Ocular Toxicology 2020; 39: 21-24 (IGR: 20-4)


82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Kim SY
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511 (IGR: 20-4)



Issue 20-4

Select Issue


advertisement

Oculus